Snorestop Double Action Kit
NDC Package 61152-200-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Snorestop Double Action (atropa belladonna, ephedra distachya flowering twig, histamine dihydrochloride, goldenseal, potassium dichromate, strychnos nux-vomica seed, teucrium marum) kits is a human otc drug administered via nasal; oral route. This formulation utilizes a kit delivery system. Marketed by Green Pharmaceuticals Inc, this product is identified by NDC 61152-200.

Identification & Billing

NDC Package Code
61152-200-60
Package Description
1 KIT in 1 BOX
Product Code
11-Digit Billing Format
61152020060

Clinical Specifications

Proprietary Name
Snorestop Double Action
Non-Proprietary Name
Atropa Belladonna, Ephedra Distachya Flowering Twig, Histamine Dihydrochloride, Goldenseal, Potassium Dichromate, Strychnos Nux-vomica Seed, Teucrium Marum
Dosage Form
Kit - A packaged collection of related material.
Administration Route
  • Nasal - Administration to the nose; administered by way of the nose.
  • Oral - Administration to or by way of the mouth.

Regulatory & Marketing

Labeler Name
Green Pharmaceuticals Inc
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
08-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61152-200-60 identifies a specific commercial package of 1 kit in 1 box of Snorestop Double Action, a human over the counter drug labeled by Green Pharmaceuticals Inc. This kit is formulated for nasal; oral use and contains as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Green Pharmaceuticals Inc on August 01, 2022. The current certification is valid through December 31, 2026.

How is this Green Pharmaceuticals Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61152020060. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61152-200-60
11-Digit CMS (5-4-2)
61152-0200-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.